Congenica Company
Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.
Founded Date:
2012-01-01
Estimated Revenue:
2.64
Total Funding:
82364942
Investors Number:
14
Number Of Exists:
11-50
Last Funding Type:
Series C
Industry:
Omics-Based Biomarkers
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Funding Status:
Late Stage Venture
Last Funding Date:
2021-03-04